2008
DOI: 10.1177/1753193408087103
|View full text |Cite
|
Sign up to set email alerts
|

Re: Spasm of the digital vessels after accidental Epipen release – A simple solution to a potentially increasing problem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…This is accepted by the plastic surgery community and identified in the emergency medicine literature [ 17 , 18 ]. Paresthesia is the most commonly reported adverse reaction to digital epinephrine, and this generally resolves in less than six months [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is accepted by the plastic surgery community and identified in the emergency medicine literature [ 17 , 18 ]. Paresthesia is the most commonly reported adverse reaction to digital epinephrine, and this generally resolves in less than six months [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…Subcutaneous injection of phentolamine or terbutaline is included in traditional treatment options. These reversal agents are considered good alternatives if necrosis, with symptoms showing no timely resolution, has been identified [ 19 , 21 ]. Two topical vasodilators, topical calcium channel blockers and topical nitroglycerin, are considered alternative, less invasive treatment methods.…”
Section: Discussionmentioning
confidence: 99%
“…Historical treatments included subcutaneous injection of phentolamine (an alpha receptor antagonist) or terbutaline (a beta receptor agonist). Although rarely used, these reversal agents continue to be good alternatives if resolution of symptoms does not improve in a timely period and necrosis is suspected [7,8]. Less invasive methods include topical vasodilators, including topical nitroglycerin and a topical calcium channel blocker, both have been used but little data to demonstrate efficacy.…”
Section: Discussionmentioning
confidence: 99%